img

Global Aminoglycosides Antibiotics Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aminoglycosides Antibiotics Drug Market Insights, Forecast to 2034

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
Market Analysis and InsightsGlobal Aminoglycosides Antibiotics Drug Market
Global Aminoglycosides Antibiotics Drug market is expected to reach to US$ 1070 million in 2024, with a positive growth of %, compared with US$ 1056 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Aminoglycosides Antibiotics Drug industry is evaluated to reach US$ 1102.5 million in 2029. The CAGR will be 0.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Aminoglycosides Antibiotics Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Aminoglycosides Antibiotics Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Aminoglycosides Antibiotics Drug introduction, etc. Aminoglycosides Antibiotics Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Aminoglycosides Antibiotics Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Etimicin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aminoglycosides Antibiotics Drug Market Perspective (2018-2029)
2.2 Global Aminoglycosides Antibiotics Drug Growth Trends by Region
2.2.1 Aminoglycosides Antibiotics Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Aminoglycosides Antibiotics Drug Historic Market Size by Region (2018-2024)
2.2.3 Aminoglycosides Antibiotics Drug Forecasted Market Size by Region (2024-2029)
2.3 Aminoglycosides Antibiotics Drug Market Dynamics
2.3.1 Aminoglycosides Antibiotics Drug Industry Trends
2.3.2 Aminoglycosides Antibiotics Drug Market Drivers
2.3.3 Aminoglycosides Antibiotics Drug Market Challenges
2.3.4 Aminoglycosides Antibiotics Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Aminoglycosides Antibiotics Drug by Players
3.1.1 Global Aminoglycosides Antibiotics Drug Revenue by Players (2018-2024)
3.1.2 Global Aminoglycosides Antibiotics Drug Revenue Market Share by Players (2018-2024)
3.2 Global Aminoglycosides Antibiotics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Aminoglycosides Antibiotics Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Aminoglycosides Antibiotics Drug Market Concentration Ratio
3.4.1 Global Aminoglycosides Antibiotics Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aminoglycosides Antibiotics Drug Revenue in 2022
3.5 Global Key Players of Aminoglycosides Antibiotics Drug Head office and Area Served
3.6 Global Key Players of Aminoglycosides Antibiotics Drug, Product and Application
3.7 Global Key Players of Aminoglycosides Antibiotics Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Aminoglycosides Antibiotics Drug Breakdown Data by Type
4.1 Global Aminoglycosides Antibiotics Drug Historic Market Size by Type (2018-2024)
4.2 Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Type (2024-2029)
5 Aminoglycosides Antibiotics Drug Breakdown Data by Application
5.1 Global Aminoglycosides Antibiotics Drug Historic Market Size by Application (2018-2024)
5.2 Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Aminoglycosides Antibiotics Drug Market Size (2018-2029)
6.2 North America Aminoglycosides Antibiotics Drug Market Size by Type
6.2.1 North America Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024)
6.2.2 North America Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029)
6.2.3 North America Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
6.3 North America Aminoglycosides Antibiotics Drug Market Size by Application
6.3.1 North America Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024)
6.3.2 North America Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029)
6.3.3 North America Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
6.4 North America Aminoglycosides Antibiotics Drug Market Size by Country
6.4.1 North America Aminoglycosides Antibiotics Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2024)
6.4.3 North America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Aminoglycosides Antibiotics Drug Market Size (2018-2029)
7.2 Europe Aminoglycosides Antibiotics Drug Market Size by Type
7.2.1 Europe Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024)
7.2.2 Europe Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029)
7.2.3 Europe Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
7.3 Europe Aminoglycosides Antibiotics Drug Market Size by Application
7.3.1 Europe Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024)
7.3.2 Europe Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029)
7.3.3 Europe Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
7.4 Europe Aminoglycosides Antibiotics Drug Market Size by Country
7.4.1 Europe Aminoglycosides Antibiotics Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2018-2024)
7.4.3 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Aminoglycosides Antibiotics Drug Market Size (2018-2029)
8.2 China Aminoglycosides Antibiotics Drug Market Size by Type
8.2.1 China Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024)
8.2.2 China Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029)
8.2.3 China Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
8.3 China Aminoglycosides Antibiotics Drug Market Size by Application
8.3.1 China Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024)
8.3.2 China Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029)
8.3.3 China Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Aminoglycosides Antibiotics Drug Market Size (2018-2029)
9.2 Asia Aminoglycosides Antibiotics Drug Market Size by Type
9.2.1 Asia Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024)
9.2.2 Asia Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029)
9.2.3 Asia Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
9.3 Asia Aminoglycosides Antibiotics Drug Market Size by Application
9.3.1 Asia Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024)
9.3.2 Asia Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029)
9.3.3 Asia Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
9.4 Asia Aminoglycosides Antibiotics Drug Market Size by Region
9.4.1 Asia Aminoglycosides Antibiotics Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Aminoglycosides Antibiotics Drug Market Size by Region (2018-2024)
9.4.3 Asia Aminoglycosides Antibiotics Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Jemicare
11.1.1 Jemicare Company Details
11.1.2 Jemicare Business Overview
11.1.3 Jemicare Aminoglycosides Antibiotics Drug Introduction
11.1.4 Jemicare Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.1.5 Jemicare Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Aminoglycosides Antibiotics Drug Introduction
11.2.4 Teva Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.2.5 Teva Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Aminoglycosides Antibiotics Drug Introduction
11.3.4 Novartis Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Fangyuan-pharma
11.4.1 Fangyuan-pharma Company Details
11.4.2 Fangyuan-pharma Business Overview
11.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Drug Introduction
11.4.4 Fangyuan-pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.4.5 Fangyuan-pharma Recent Developments
11.5 Aike Pharmaceutical
11.5.1 Aike Pharmaceutical Company Details
11.5.2 Aike Pharmaceutical Business Overview
11.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Drug Introduction
11.5.4 Aike Pharmaceutical Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.5.5 Aike Pharmaceutical Recent Developments
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Aminoglycosides Antibiotics Drug Introduction
11.6.4 Cipla Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.6.5 Cipla Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Aminoglycosides Antibiotics Drug Introduction
11.7.4 Pfizer Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.7.5 Pfizer Recent Developments
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Details
11.8.2 Fresenius Kabi Business Overview
11.8.3 Fresenius Kabi Aminoglycosides Antibiotics Drug Introduction
11.8.4 Fresenius Kabi Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.8.5 Fresenius Kabi Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Aminoglycosides Antibiotics Drug Introduction
11.9.4 Sun Pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.9.5 Sun Pharma Recent Developments
11.10 Hikma
11.10.1 Hikma Company Details
11.10.2 Hikma Business Overview
11.10.3 Hikma Aminoglycosides Antibiotics Drug Introduction
11.10.4 Hikma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.10.5 Hikma Recent Developments
11.11 Lannett Company
11.11.1 Lannett Company Company Details
11.11.2 Lannett Company Business Overview
11.11.3 Lannett Company Aminoglycosides Antibiotics Drug Introduction
11.11.4 Lannett Company Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024)
11.11.5 Lannett Company Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Neomycin
Table 3. Key Players of Tobramycin
Table 4. Key Players of Gentamicin
Table 5. Key Players of Amikacin
Table 6. Key Players of Etimicin
Table 7. Key Players of Others
Table 8. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 9. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Aminoglycosides Antibiotics Drug Market Size by Region (2018-2024) & (US$ Million)
Table 11. Global Aminoglycosides Antibiotics Drug Market Share by Region (2018-2024)
Table 12. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Aminoglycosides Antibiotics Drug Market Share by Region (2024-2029)
Table 14. Aminoglycosides Antibiotics Drug Market Trends
Table 15. Aminoglycosides Antibiotics Drug Market Drivers
Table 16. Aminoglycosides Antibiotics Drug Market Challenges
Table 17. Aminoglycosides Antibiotics Drug Market Restraints
Table 18. Global Aminoglycosides Antibiotics Drug Revenue by Players (2018-2024) & (US$ Million)
Table 19. Global Aminoglycosides Antibiotics Drug Revenue Share by Players (2018-2024)
Table 20. Global Top Aminoglycosides Antibiotics Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics Drug as of 2022)
Table 21. Global Aminoglycosides Antibiotics Drug Industry Ranking 2021 VS 2022 VS 2024
Table 22. Global 5 Largest Players Market Share by Aminoglycosides Antibiotics Drug Revenue (CR5 and HHI) & (2018-2024)
Table 23. Global Key Players of Aminoglycosides Antibiotics Drug, Headquarters and Area Served
Table 24. Global Key Players of Aminoglycosides Antibiotics Drug, Product and Application
Table 25. Global Key Players of Aminoglycosides Antibiotics Drug, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 28. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2018-2024)
Table 29. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2024-2029)
Table 31. Global Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 32. Global Aminoglycosides Antibiotics Drug Revenue Share by Application (2018-2024)
Table 33. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Aminoglycosides Antibiotics Drug Revenue Share by Application (2024-2029)
Table 35. North America Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 36. North America Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 37. North America Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 38. North America Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 39. North America Aminoglycosides Antibiotics Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. North America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 41. North America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 42. Europe Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 43. Europe Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 44. Europe Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 45. Europe Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 46. Europe Aminoglycosides Antibiotics Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 48. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. China Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. China Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. China Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. China Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 54. Asia Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 55. Asia Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 56. Asia Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 57. Asia Aminoglycosides Antibiotics Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 58. Asia Aminoglycosides Antibiotics Drug Market Size by Region (2018-2024) & (US$ Million)
Table 59. Asia Aminoglycosides Antibiotics Drug Market Size by Region (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 65. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 67. Jemicare Company Details
Table 68. Jemicare Business Overview
Table 69. Jemicare Aminoglycosides Antibiotics Drug Product
Table 70. Jemicare Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 71. Jemicare Recent Developments
Table 72. Teva Company Details
Table 73. Teva Business Overview
Table 74. Teva Aminoglycosides Antibiotics Drug Product
Table 75. Teva Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 76. Teva Recent Developments
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Aminoglycosides Antibiotics Drug Product
Table 80. Novartis Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 81. Novartis Recent Developments
Table 82. Fangyuan-pharma Company Details
Table 83. Fangyuan-pharma Business Overview
Table 84. Fangyuan-pharma Aminoglycosides Antibiotics Drug Product
Table 85. Fangyuan-pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 86. Fangyuan-pharma Recent Developments
Table 87. Aike Pharmaceutical Company Details
Table 88. Aike Pharmaceutical Business Overview
Table 89. Aike Pharmaceutical Aminoglycosides Antibiotics Drug Product
Table 90. Aike Pharmaceutical Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 91. Aike Pharmaceutical Recent Developments
Table 92. Cipla Company Details
Table 93. Cipla Business Overview
Table 94. Cipla Aminoglycosides Antibiotics Drug Product
Table 95. Cipla Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 96. Cipla Recent Developments
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Aminoglycosides Antibiotics Drug Product
Table 100. Pfizer Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 101. Pfizer Recent Developments
Table 102. Fresenius Kabi Company Details
Table 103. Fresenius Kabi Business Overview
Table 104. Fresenius Kabi Aminoglycosides Antibiotics Drug Product
Table 105. Fresenius Kabi Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 106. Fresenius Kabi Recent Developments
Table 107. Sun Pharma Company Details
Table 108. Sun Pharma Business Overview
Table 109. Sun Pharma Aminoglycosides Antibiotics Drug Product
Table 110. Sun Pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 111. Sun Pharma Recent Developments
Table 112. Hikma Company Details
Table 113. Hikma Business Overview
Table 114. Hikma Aminoglycosides Antibiotics Drug Product
Table 115. Hikma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 116. Hikma Recent Developments
Table 117. Lannett Company Company Details
Table 118. Lannett Company Business Overview
Table 119. Lannett Company Aminoglycosides Antibiotics Drug Product
Table 120. Lannett Company Revenue in Aminoglycosides Antibiotics Drug Business (2018-2024) & (US$ Million)
Table 121. Lannett Company Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Aminoglycosides Antibiotics Drug Market Share by Type: 2022 VS 2029
Figure 3. Neomycin Features
Figure 4. Tobramycin Features
Figure 5. Gentamicin Features
Figure 6. Amikacin Features
Figure 7. Etimicin Features
Figure 8. Others Features
Figure 9. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Aminoglycosides Antibiotics Drug Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Aminoglycosides Antibiotics Drug Report Years Considered
Figure 15. Global Aminoglycosides Antibiotics Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Aminoglycosides Antibiotics Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Aminoglycosides Antibiotics Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Aminoglycosides Antibiotics Drug Market Share by Players in 2022
Figure 19. Global Top Aminoglycosides Antibiotics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Aminoglycosides Antibiotics Drug Revenue in 2022
Figure 21. North America Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
Figure 23. North America Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
Figure 24. North America Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 25. United States Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Aminoglycosides Antibiotics Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
Figure 29. Europe Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
Figure 30. Europe Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 31. Germany Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Aminoglycosides Antibiotics Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
Figure 39. China Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
Figure 40. Asia Aminoglycosides Antibiotics Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
Figure 42. Asia Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
Figure 43. Asia Aminoglycosides Antibiotics Drug Market Share by Region (2018-2029)
Figure 44. Japan Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 54. Brazil Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Jemicare Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 61. Teva Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 62. Novartis Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 63. Fangyuan-pharma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 64. Aike Pharmaceutical Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 65. Cipla Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 66. Pfizer Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 67. Fresenius Kabi Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 68. Sun Pharma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 69. Hikma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 70. Lannett Company Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries